{
    "info": {
        "nct_id": "NCT03655678",
        "official_title": "A Phase 1/2/3 Study of the Safety and Efficacy of a Single Dose of Autologous CRISPR-Cas9 Modified CD34+ Human Hematopoietic Stem and Progenitor Cells (hHSPCs) in Subjects With Transfusion-Dependent β-Thalassemia",
        "inclusion_criteria": "* Diagnosis of transfusion-dependent β-thalassemia (TDT) as defined by\n\n  1. Documented homozygous β-thalassemia or compound heterozygous β-thalassemia including β-thalassemia/hemoglobin E (HbE). Participants can be enrolled based on historical data, but a confirmation of the genotype using the study central laboratory will be required before busulfan conditioning\n  2. History of at least 100 mL/kg/year or ≥10 units/year of packed RBC transfusions in the prior 2 years before signing the consent or the last rescreening for patients going through re-screening\n* Eligible for autologous stem cell transplant as per investigator's judgment\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 12 Years\nMust have maximum age of 35 Years",
        "exclusion_criteria": "* A willing and healthy 10/10 Human Leukocyte Antigen (HLA)-matched related donor is available per investigator's judgement\n* Prior allo-HSCT\n* Participants with associated α-thalassemia and >1 alpha deletion or alpha multiplications\n* Participants with sickle cell beta thalassemia variant\n* Clinically significant and active bacterial, viral, fungal, or parasitic infection as determined by the investigator\n* White blood cell (WBC) count <3 × 10^9/L or platelet count <50 × 10^9/L not related to hypersplenism\n\nOther protocol defined Inclusion/Exclusion criteria may apply.",
        "miscellaneous_criteria": "Key"
    },
    "inclusion_lines": [
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Key",
            "criterions": [
                {
                    "exact_snippets": "Key",
                    "criterion": "key status",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "Key"
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. History of at least 100 mL/kg/year or ≥10 units/year of packed RBC transfusions in the prior 2 years before signing the consent or the last rescreening for patients going through re-screening",
            "criterions": [
                {
                    "exact_snippets": "History of at least 100 mL/kg/year ... of packed RBC transfusions in the prior 2 years",
                    "criterion": "packed RBC transfusions",
                    "requirements": [
                        {
                            "requirement_type": "quantity per year",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100,
                                "unit": "mL/kg/year"
                            }
                        },
                        {
                            "requirement_type": "time frame",
                            "expected_value": "in the prior 2 years"
                        }
                    ]
                },
                {
                    "exact_snippets": "History of ... ≥10 units/year of packed RBC transfusions in the prior 2 years",
                    "criterion": "packed RBC transfusions",
                    "requirements": [
                        {
                            "requirement_type": "quantity per year",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "units/year"
                            }
                        },
                        {
                            "requirement_type": "time frame",
                            "expected_value": "in the prior 2 years"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Documented homozygous β-thalassemia or compound heterozygous β-thalassemia including β-thalassemia/hemoglobin E (HbE). Participants can be enrolled based on historical data, but a confirmation of the genotype using the study central laboratory will be required before busulfan conditioning",
            "criterions": [
                {
                    "exact_snippets": "Documented homozygous β-thalassemia or compound heterozygous β-thalassemia including β-thalassemia/hemoglobin E (HbE)",
                    "criterion": "β-thalassemia genotype",
                    "requirements": [
                        {
                            "requirement_type": "genotype",
                            "expected_value": [
                                "homozygous β-thalassemia",
                                "compound heterozygous β-thalassemia",
                                "β-thalassemia/hemoglobin E (HbE)"
                            ]
                        },
                        {
                            "requirement_type": "documentation",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "confirmation of the genotype using the study central laboratory will be required before busulfan conditioning",
                    "criterion": "β-thalassemia genotype confirmation",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": "study central laboratory"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "before busulfan conditioning"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 35 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 35 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 35,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diagnosis of transfusion-dependent β-thalassemia (TDT) as defined by",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of transfusion-dependent β-thalassemia (TDT)",
                    "criterion": "transfusion-dependent β-thalassemia (TDT)",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Eligible for autologous stem cell transplant as per investigator's judgment",
            "criterions": [
                {
                    "exact_snippets": "Eligible for autologous stem cell transplant as per investigator's judgment",
                    "criterion": "eligibility for autologous stem cell transplant",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "determination method",
                            "expected_value": "investigator's judgment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 12 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 12 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 12,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Participants with associated α-thalassemia and >1 alpha deletion or alpha multiplications",
            "criterions": [
                {
                    "exact_snippets": "associated α-thalassemia",
                    "criterion": "α-thalassemia",
                    "requirements": [
                        {
                            "requirement_type": "association",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": ">1 alpha deletion",
                    "criterion": "alpha gene deletion",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "N/A"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "alpha multiplications",
                    "criterion": "alpha gene multiplication",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior allo-HSCT",
            "criterions": [
                {
                    "exact_snippets": "Prior allo-HSCT",
                    "criterion": "prior allogeneic hematopoietic stem cell transplantation (allo-HSCT)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Other protocol defined Inclusion/Exclusion criteria may apply.",
            "criterions": [
                {
                    "exact_snippets": "Other protocol defined Inclusion/Exclusion criteria may apply.",
                    "criterion": "other protocol defined inclusion/exclusion criteria",
                    "requirements": [
                        {
                            "requirement_type": "applicability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* White blood cell (WBC) count <3 × 10^9/L or platelet count <50 × 10^9/L not related to hypersplenism",
            "criterions": [
                {
                    "exact_snippets": "White blood cell (WBC) count <3 × 10^9/L",
                    "criterion": "white blood cell (WBC) count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 3,
                                "unit": "× 10^9/L"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "platelet count <50 × 10^9/L",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 50,
                                "unit": "× 10^9/L"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "not related to hypersplenism",
                    "criterion": "cytopenia etiology",
                    "requirements": [
                        {
                            "requirement_type": "relation to hypersplenism",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* A willing and healthy 10/10 Human Leukocyte Antigen (HLA)-matched related donor is available per investigator's judgement",
            "criterions": [
                {
                    "exact_snippets": "A willing ... donor is available",
                    "criterion": "donor",
                    "requirements": [
                        {
                            "requirement_type": "availability",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "10/10 Human Leukocyte Antigen (HLA)-matched related donor",
                    "criterion": "donor HLA match",
                    "requirements": [
                        {
                            "requirement_type": "HLA match",
                            "expected_value": "10/10"
                        },
                        {
                            "requirement_type": "relatedness",
                            "expected_value": "related"
                        }
                    ]
                },
                {
                    "exact_snippets": "healthy ... donor",
                    "criterion": "donor health status",
                    "requirements": [
                        {
                            "requirement_type": "health status",
                            "expected_value": "healthy"
                        }
                    ]
                },
                {
                    "exact_snippets": "per investigator's judgement",
                    "criterion": "investigator judgement",
                    "requirements": [
                        {
                            "requirement_type": "investigator judgement",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Clinically significant and active bacterial, viral, fungal, or parasitic infection as determined by the investigator",
            "criterions": [
                {
                    "exact_snippets": "Clinically significant and active bacterial, viral, fungal, or parasitic infection as determined by the investigator",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "bacterial",
                                "viral",
                                "fungal",
                                "parasitic"
                            ]
                        },
                        {
                            "requirement_type": "clinical_significance",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "activity_status",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "determined_by",
                            "expected_value": "investigator"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Participants with sickle cell beta thalassemia variant",
            "criterions": [
                {
                    "exact_snippets": "Participants with sickle cell beta thalassemia variant",
                    "criterion": "sickle cell beta thalassemia variant",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [
        {
            "line": "Key",
            "criterions": [
                {
                    "exact_snippets": "Key",
                    "criterion": "key eligibility criteria",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "N/A"
                        }
                    ]
                }
            ]
        }
    ],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}